Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 5, 2003, Pages 751-757

  Chetta, Alfredo ^a   Zanini, Andrea ^b   Foresi, Antonio ^b   Del Donno, Mario ^b   Castagnaro, Antonio ^b   D'Ippolito, Raffaele ^b   Baraldo, Simonetta ^b   Testi, Renato ^b   Saetta, Marina ^b   Olivieri, Dario ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b NONE

Author keywords

Airway inflammation; Asthma; Bronchial biopsy; Inhaled steroids

Indexed keywords

FLUTICASONE PROPIONATE; METHACHOLINE; ANDROSTANE DERIVATIVE; ANTIINFLAMMATORY AGENT; BRONCHOCONSTRICTING AGENT; BRONCHODILATING AGENT; DIAGNOSTIC AGENT; FLUTICASONE; GLUCOCORTICOID; METHACHOLINE CHLORIDE;

ADULT; ANGIOGENESIS; ARTICLE; ASTHMA; BASEMENT MEMBRANE; BRONCHUS BIOPSY; BRONCHUS REACTIVITY; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; LOW DRUG DOSE; LUNG STRUCTURE; MALE; MAST CELL; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHORT COURSE THERAPY; SUBMUCOSA; SYMPTOM; THICKNESS; TISSUE REPAIR; VASCULARIZATION; ADOLESCENT; BIOPSY; BRONCHUS; COMPARATIVE STUDY; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; TIME; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; BASEMENT MEMBRANE; BIOPSY; BRONCHI; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MALE; METHACHOLINE CHLORIDE; TIME FACTORS;

EID: 0037365622     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200207-710OC     Document Type: Article

References (38)

1. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993;147:405-410.
2. Takizawa T, Thurlbeck WM. Muscle and mucous gland size in the major bronchi of patients with chronic bronchitis, asthma, and asthmatic bronchitis. Am Rev Respir Dis 1971;104:331-336.
3. Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997;111:852-857.
4. Dunnill MS. The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 1960;13:27-33.
5. Dunnill MS, Massarella GR, Anderson JA. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis and in emphysema. Thorax 1969;24:176-179.
6. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997;156:229-233.
7. Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 2001;56:902-906.
8. Chediak AD, Wanner A. Effects of histamine on tracheal mucosal perfusion, water content and airway smooth muscle in sheep. Respir Physiol 1991;84:231-242.
9. Laitinen LA, Laitinen A, Widdicombe J. Effects of inflammatory, and other mediators on airway vascular beds. Am Rev Respir Dis 1987;135:S67-S70.
10. D'Amore P. Mechanisms of endothelial growth control. Am J Respir Cell Mol Biol 1992;6:1-8.
11. Moreno RH, Hogg JC, Pare PD. Mechanics of airway narrowing. Am Rev Respir Dis 1986;133:1171-1180.
12. Booth H, Richmond I, Ward C, Gardiner PV, Harkawat R, Walters EH. Effect of high-dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med 1995;152:45-52.
13. Olivieri D, Chetta A, Del Donno M, Bertorelli G, Casalini A, Pesci A, Testi R, Foresi A. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997;155:1864-1871.
14. Orsida BE, Li X, Hickey B, Thien F, Wilson JW, Walters EH. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 1999;54:289-295.
15. Hoshino M, Takahashi M, Takai Y, Sim J, Aoike N. Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma. Clin Exp Allergy 2001;31:722-730.
16. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-664.
17. Sterk PJ, Fabbri LM, Quarnier PhH, Cockcroft DW, O'Byrne PM, Anderson SD, Juniper EF, Malo JL. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993;6:53-58.
18. American Thoracic Society. Standards for diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
19. Britten KM, Howarth PH, Roche WR. Immunohistochemistry of resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem 1993;68:271-280.
20. Sullivan P, Stephens D, Ansari T, Costello J, Jeffery P. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. Eur Respir J 1998;12:811-815.
21. Vrugt B, Wilson S, Bron A, Holgate ST, Djukanovic R, Aalbers R. Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur Respir J 2000;15:1014-1021.
22. McDonald DM. Angiogenesis and remodeling of airways vasculature in chronic inflammation. Am J Respir Crit Care Med 2001;164:S39-S45.
23. Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 2001;107:1034-1038.
24. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
25. Sorbo J, Jakobsson A, Norrby K. Mast-cell histamine is angiogenic through receptors for histamine 1 and histamine 2. Int J Exp Pathol 1994;75:43-50.
26. Azizkhan RG, Azizkhan JC, Zetter BR, Folkman J. Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med 1980;152:931-944.
27. Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor 1 expression. J Exp Med 1998;188:1135-1145.
28. Gruber BL, Marchese MJ, Kew R. Angiogenic factors stimulate mast-cell migration. Blood 1995;86:2488-2493.
29. Senger DR, Van De Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, Dvorak HF. Vascular permeability factor (VPF,VEGF) in tumor biology. Cancer Metastasis Rev 1993;12:303-324.
30. Wang JH, Trigg CJ, Devalia JL, Jordan S, Davies RJ. Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthma. J Allergy Clin Immunol 1994;94:1025-1034.
31. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998;341:309-315.
32. Kumar SD, Brieva JL, Danta I, Wanner A. Transient effect of inhaled fluticasone on airway mucosal blood flow in subjects with and without asthma. Am J Respir Crit Care Med 2000;161:918-921.
33. 2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med 2001;164:117-121.
34. Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, Walters EH. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002;57:309-316.
35. Trigg CJ, Manolitsas ND, Wang J, Calderon MA, McAulay A, Jordan SE, Herdman MJ, Jhalli N, Duddle JM, Hamilton SA, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994;150:17-22.
36. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johanson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992;145:890-899.
37. Holt S, Suder A, Weatherall M, Cheng S, Shirtcliffe P, Beasley R. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ 2001;323:1-8.
38. Sont JK, Willems LNA, Bel EH, van Krieken HJM, Vandenbroucke JP, Sterk PJ and the AMPUL Study Group. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999;159:1043-1051.